Overview

Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
Sodium nitrite has been demonstrated to promote new blood vessel growth, speed up wound healing and prevent tissue necrosis in animals. Since patients with PAD experience many of these problems, this study will seek to determine whether this drug, when given orally, could provide the same benefits to patients with PAD.
Phase:
Phase 2
Details
Lead Sponsor:
TheraVasc Inc.